Review



sd biosensor v2  (SD Biosensor)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    SD Biosensor sd biosensor v2
    Sd Biosensor V2, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sd+biosensor+v2/sd+biosensor+v1/pmc08774861-137-9-7
    Average 90 stars, based on 1 article reviews
    sd biosensor v2 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers
    Article Snippet: The median values of the Abbott, SD Biosensor V1, and SD Biosensor V2 assays showing positivity in baseline samples were 1.5 AU/ml (1st to 3rd quartile range, 0.5 to 3.3 AU/ml), 11.2% (1st to 3rd quartile range, 7.5 to 15.4%), and 8.3% (1st to 3rd quartile range, 5.4 to 11.9%), respectively.

    Article Title: Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer
    Article Snippet: One sample from Roche total, two from SD Biosensor V2, and two from GenScript at T3 showed increased titers when compared to those at T2.

    Article Title: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers
    Article Snippet: SD Biosensor only positive (V1 positive or V2 positive) , 2 (2.2) , 0.4 (0.4–0.4) , 11.2 (0.6–21.7) , 0.2 (0.1–0.3) , 13.6 (7.5–19.7) , 38.2 (33.5–41.1).

    Significance Assay:

    Article Title: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers
    Article Snippet: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers Seri Jeong,a Nuri Lee,a Su Kyung Lee,b Eun-Jung Cho,b Jungwon Hyun,b Min-Jeong Park,a Wonkeun Song,a Eun Ju Jung,c Heungjeong Woo,c Yu Bin Seo,d Jin Ju Park,d Hyun Soo Kimb# Supplementary information Supplemental Table 1. .. Quantitative median values of SARS-CoV-2 antibody assays according to the characteristics of participants Supplemental Table 1 Quantitative median values of SARS-CoV-2 antibody assays according to the characteristics of participantsa Characteristics Roche (U/mL) P-value Abbott (AU/mL) P-value Siemens (index) P-value SD biosensor V1 (%) P-value SD biosensor V2 (%) P-value GenScript (%) P-value Sex 0.070 0.081 0.035 0.184 0.019 0.274 Male (n = 36) 12.1 418.8 5.4 86.8 66.8 48.5 Female (n = 192) 7.5 265.3 2.6 79.9 49.8 39.7 Age 0.838 0.603 0.552 0.405 0.874 0.940 21-30 (n = 101) 9.0 306.0 3.1 79.9 52.2 40.3 31-40 (n = 50) 6.4 329.2 3.8 85.5 53.7 42.9 41-50 (n = 46) 6.8 225.1 2.1 71.5 47.1 36.7 51-60 (n = 31) 8.1 280.8 2.7 82.3 55.2 43.9 Occupation 0.130 0.011 0.018 0.038 0.012 0.049 Doctor (n = 14) 15.8 531.2 5.6 91.6 68.1 56.7 Nurse (n = 154) 6.4 245.2 2.2 78.2 46.7 36.6 Medical technician (n = 58) 9.3 418.8 3.6 83.7 58.6 43.7 Others (n = 2) 16.0 360.5 4.0 74.4 55.7 37.3 Days after vaccination < 0.001 0.002 0.006 0.005 0.001 0.001 11-20 days (n = 179) 6.5 251.1 2.6 78.9 47.3 36.6 21-28 days (n = 49) 16.8 417.0 4.0 88.3 65.0 49.8 Adverse reactions after vaccination 0.017 0.003 0.01 0.009 0.002 0.011 Absent (n = 8) 1.4 76.6 0.7 45.1 18.2 21.0 Mild (n = 152) 6.4 259.7 2.8 78.2 50.0 37.3 Severe (n = 68) 10.6 394.8 3.4 86.2 57.7 45.6 Duration of adverse reactions 0.011 0.002 0.034 0.05 0.04 0.015 < 1 day (n = 59) 5.1 182.1 2.2 74.8 45.5 34.8 2-3 days (n = 141) 10.1 318.3 3.3 85.3 55.5 44.5 > 4 days (n = 20) 12.6 687.6 4.7 84.1 65.8 60.3 Antipyretics 0.875 0.353 0.705 0.594 0.094 0.836 Not taken (n = 23) 8.8 197.9 2.6 76.2 41.7 35.7 Taken (n = 205) 7.6 284.2 3.1 81.6 52.7 40.8 Total after vaccination (n = 228) 7.8 278.4 3.0 80.3 51.1 40.3 aData are expressed as medians. ..

    Injection:

    Article Title: Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer
    Article Snippet: .. The positive rates seven months after the first injection for all the assays were decreased (97.0% for Abbott IgG, 86.0% for Siemens IgG, 98.0% for SD Biosensor V1, 92.0% for SD Biosensor V2, and 66.0% for the GenScript assay) when compared to the rates after the second dose, except for Roche total (100.0%). ..



    Similar Products

    sd biosensor v2  (SD Biosensor)
    90
    SD Biosensor sd biosensor v2
    Sd Biosensor V2, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sd+biosensor+v2/sd+biosensor+v1/pmc08774861-137-9-7
    Average 90 stars, based on 1 article reviews
    sd biosensor v2 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    sd biosensor v2 assay  (SD Biosensor)
    90
    SD Biosensor sd biosensor v2 assay
    Quantitative serological responses before and after the first and second doses of the AstraZeneca vaccine according to the Roche total Ab (A), Abbott IgG (B), Siemens IgG (C), <t>SD</t> <t>Biosensor</t> V1 neutralizing antibody (D), SD Biosensor <t>V2</t> neutralizing antibody (E), and GenScript neutralizing antibody (F) assays. P values were calculated using the Kruskal-Wallis test for the quantitative differences between before and after the first and second vaccinations. The differences among the results at baseline and after the first and second vaccinations for all included assays were significant ( P < 0.001). The cutoff for each assay is shown as a dashed line.
    Sd Biosensor V2 Assay, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sd+biosensor+v2/sd+biosensor+v2+assay/pmc08601234-179-3-1
    Average 90 stars, based on 1 article reviews
    sd biosensor v2 assay - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    sd biosensor v1 versus sd biosensor v2  (SD Biosensor)
    90
    SD Biosensor sd biosensor v1 versus sd biosensor v2
    Quantitative serological responses before and after the first and second doses of the AstraZeneca vaccine according to the Roche total Ab (A), Abbott IgG (B), Siemens IgG (C), <t>SD</t> <t>Biosensor</t> V1 neutralizing antibody (D), SD Biosensor <t>V2</t> neutralizing antibody (E), and GenScript neutralizing antibody (F) assays. P values were calculated using the Kruskal-Wallis test for the quantitative differences between before and after the first and second vaccinations. The differences among the results at baseline and after the first and second vaccinations for all included assays were significant ( P < 0.001). The cutoff for each assay is shown as a dashed line.
    Sd Biosensor V1 Versus Sd Biosensor V2, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sd+biosensor+v2/sd+biosensor+v1+versus+sd+biosensor+v2/pmc08601234__jcm__01788___21___s0001-0-133-133
    Average 90 stars, based on 1 article reviews
    sd biosensor v1 versus sd biosensor v2 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    sd biosensor v2 neutralizing antibody  (SD Biosensor)
    90
    SD Biosensor sd biosensor v2 neutralizing antibody
    Quantitative serological responses before and after the first and second doses of the AstraZeneca vaccine according to the Roche total Ab (A), Abbott IgG (B), Siemens IgG (C), SD Biosensor V1 <t>neutralizing</t> antibody (D), SD Biosensor <t>V2</t> neutralizing antibody (E), and GenScript neutralizing antibody (F) assays. P values were calculated using the Kruskal-Wallis test for the quantitative differences between before and after the first and second vaccinations. The differences among the results at baseline and after the first and second vaccinations for all included assays were significant ( P < 0.001). The cutoff for each assay is shown as a dashed line.
    Sd Biosensor V2 Neutralizing Antibody, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sd+biosensor+v2/sd+biosensor+v1+neutralizing+antibody/pmc08601234-183-76-74
    Average 90 stars, based on 1 article reviews
    sd biosensor v2 neutralizing antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    igg sd biosensor v2 nab  (SD Biosensor)
    90
    SD Biosensor igg sd biosensor v2 nab
    Correlations among five SARS-CoV-2 antibody assays
    Igg Sd Biosensor V2 Nab, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sd+biosensor+v2/sd+biosensor+v2+assay/pmc08601234-100-0-1
    Average 90 stars, based on 1 article reviews
    igg sd biosensor v2 nab - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Quantitative serological responses before and after the first and second doses of the AstraZeneca vaccine according to the Roche total Ab (A), Abbott IgG (B), Siemens IgG (C), SD Biosensor V1 neutralizing antibody (D), SD Biosensor V2 neutralizing antibody (E), and GenScript neutralizing antibody (F) assays. P values were calculated using the Kruskal-Wallis test for the quantitative differences between before and after the first and second vaccinations. The differences among the results at baseline and after the first and second vaccinations for all included assays were significant ( P < 0.001). The cutoff for each assay is shown as a dashed line.

    Journal: Journal of Clinical Microbiology

    Article Title: Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study

    doi: 10.1128/JCM.01788-21

    Figure Lengend Snippet: Quantitative serological responses before and after the first and second doses of the AstraZeneca vaccine according to the Roche total Ab (A), Abbott IgG (B), Siemens IgG (C), SD Biosensor V1 neutralizing antibody (D), SD Biosensor V2 neutralizing antibody (E), and GenScript neutralizing antibody (F) assays. P values were calculated using the Kruskal-Wallis test for the quantitative differences between before and after the first and second vaccinations. The differences among the results at baseline and after the first and second vaccinations for all included assays were significant ( P < 0.001). The cutoff for each assay is shown as a dashed line.

    Article Snippet: The SD Biosensor V2 assay, targeting antibodies to the South Africa/Brazil variant of SARS-CoV-2, as well as the SD Biosensor V1 assay, targeting antibodies to the original Wuhan SARS-CoV-2 and the UK variant, revealed 100.0% positivity.

    Techniques:

    Quantitative serological responses after the first and second dose of AstraZeneca vaccine according to the changes in antibody titer <xref ref-type= a " width="100%" height="100%">

    Journal: Journal of Clinical Microbiology

    Article Title: Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study

    doi: 10.1128/JCM.01788-21

    Figure Lengend Snippet: Quantitative serological responses after the first and second dose of AstraZeneca vaccine according to the changes in antibody titer a

    Article Snippet: The SD Biosensor V2 assay, targeting antibodies to the South Africa/Brazil variant of SARS-CoV-2, as well as the SD Biosensor V1 assay, targeting antibodies to the original Wuhan SARS-CoV-2 and the UK variant, revealed 100.0% positivity.

    Techniques: Titer Assay

    Correlations among five SARS-CoV-2 antibody assays

    Journal: Journal of Clinical Microbiology

    Article Title: Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study

    doi: 10.1128/JCM.01788-21

    Figure Lengend Snippet: Correlations among five SARS-CoV-2 antibody assays

    Article Snippet: The SD Biosensor V2 assay, targeting antibodies to the South Africa/Brazil variant of SARS-CoV-2, as well as the SD Biosensor V1 assay, targeting antibodies to the original Wuhan SARS-CoV-2 and the UK variant, revealed 100.0% positivity.

    Techniques:

    Quantitative serological responses before and after the first and second doses of the AstraZeneca vaccine according to the Roche total Ab (A), Abbott IgG (B), Siemens IgG (C), SD Biosensor V1 neutralizing antibody (D), SD Biosensor V2 neutralizing antibody (E), and GenScript neutralizing antibody (F) assays. P values were calculated using the Kruskal-Wallis test for the quantitative differences between before and after the first and second vaccinations. The differences among the results at baseline and after the first and second vaccinations for all included assays were significant ( P < 0.001). The cutoff for each assay is shown as a dashed line.

    Journal: Journal of Clinical Microbiology

    Article Title: Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study

    doi: 10.1128/JCM.01788-21

    Figure Lengend Snippet: Quantitative serological responses before and after the first and second doses of the AstraZeneca vaccine according to the Roche total Ab (A), Abbott IgG (B), Siemens IgG (C), SD Biosensor V1 neutralizing antibody (D), SD Biosensor V2 neutralizing antibody (E), and GenScript neutralizing antibody (F) assays. P values were calculated using the Kruskal-Wallis test for the quantitative differences between before and after the first and second vaccinations. The differences among the results at baseline and after the first and second vaccinations for all included assays were significant ( P < 0.001). The cutoff for each assay is shown as a dashed line.

    Article Snippet: The median values of the Roche, Abbott IgG, Siemens IgG, SD Biosensor V1, SD Biosensor V2, and GenScript assay results in the samples after the second dose were 830.0 U/ml, 1,003.7 AU/ml, 10.8 index, 99.5%, 97.4%, and 88.0%, respectively, which showed that the second dose of vaccination led to a significant increase of 106.4-fold for Roche total antibody, 3.6-fold for Abbott IgG, 3.6-fold for Siemens, 1.2-fold for SD Biosensor V1 neutralizing antibody, 1.9-fold for SD Biosensor V2 neutralizing antibody, and 2.2-fold for GenScript neutralizing antibody compared to the first dose ( ).

    Techniques:

    Correlations among five SARS-CoV-2 antibody assays

    Journal: Journal of Clinical Microbiology

    Article Title: Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study

    doi: 10.1128/JCM.01788-21

    Figure Lengend Snippet: Correlations among five SARS-CoV-2 antibody assays

    Article Snippet: Abbott IgG/SD Biosensor V2 nAb , 0.908 , <0.001.

    Techniques: